久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Fighting cancer with genetics

Updated: 2012-07-29 07:13

By Gina Kolata(The New York Times)

  Print Mail Large Medium  Small

St. Louis - Genetics researchers here at Washington University, one of the world's leading centers for work on the human genome, were devastated. Dr. Lukas Wartman, a young, talented and beloved colleague, had the very cancer he had devoted his career to studying. So one day last July, Dr. Timothy Ley, associate director of the university's genome institute, summoned his team. Why not dedicate everything we can to see if we can find a rogue gene spurring Dr. Wartman's cancer, adult acute lymphoblastic leukemia, he asked? "It's now or never," he recalled telling them. "We will only get one shot."

Dr. Ley's team tried a type of analysis that they had never done before. They fully sequenced the genes of both his cancer cells and healthy cells for comparison, and at the same time analyzed his RNA, a close chemical cousin to DNA, for clues to what his genes were doing.

The researchers on the project put other work aside for weeks, running one of the university's 26 sequencing machines and supercomputer around the clock. And they found a culprit - a normal gene that was in overdrive, churning out huge amounts of a protein that appeared to be spurring the cancer's growth.

Even better, there was a promising new drug that might shut down the malfunctioning gene - a drug that had been tested and approved only for advanced kidney cancer. Dr. Wartman became the first person ever to take it for leukemia. And now his cancer is in remission and has been since last fall.

While no one can say that Dr. Wartman is cured, after facing certain death last fall, he is alive and doing well. Dr. Wartman is a pioneer in a new approach to stopping cancer. What is important, medical researchers say, is the genes that drive a cancer, not the tissue or organ where the cancer originates.

One woman's breast cancer may have different genetic drivers from another woman's and, in fact, may have more in common with prostate cancer in a man or another patient's lung cancer.

Fighting cancer with genetics

Under this new approach, researchers expect that treatment will be tailored to an individual tumor's mutations, with drugs that hit several key aberrant genes at once. The cocktails of medicine would be analogous to H.I.V. treatment, which uses several different drugs at once.

Researchers differ about how soon the method, known as whole genome sequencing, will be generally available and paid for by insurance. But they believe that it has enormous promise.

"Until you know what is driving a patient's cancer, you really don't have any chance of getting it right," Dr. Ley said. "For the past 40 years, we have been sending generals into battle without a map of the battlefield. What we are doing now is building the map."

For now, whole genome sequencing is in its infancy and dauntingly complex. The gene sequences are only the start. The arduous job is to figure out which mutations are important.

So far, most who have chosen this path are wealthy and well connected. When Steve Jobs had exhausted other options to combat pancreatic cancer, he consulted doctors who coordinated his genetic sequencing and analysis. It cost him $100,000, according to his biographer.

Dr. Wartman was included by his colleagues in a research study, and his genetic analysis was paid for by the university and research grants. Such opportunities are not available to most patients, but Dr. Ley noted that no patients were being neglected because of the urgent work to figure out Dr. Wartman's cancer.

A Life in Medicine

In college, Dr. Wartman was drawn to research on genetic changes that occur in cancers of the blood. In the winter of 2002, when he went to California to be interviewed for a residency program at Stanford University, he was nearly paralyzed by an overwhelming fatigue.

He rallied enough to get through the day. When he returned to St. Louis, he gave up running, too exhausted for the sport he loved. He started having night sweats. "I thought it might be mono," he said. "And I thought I would ride it out."

But then the bones in his legs began to hurt. He was having fevers. He went to an urgent care center in February 2003. The doctor noticed that his red and white blood cell counts were low. And Lukas Wartman, who had been fascinated by the biology of leukemia, began to suspect he had it.

The next day, he went back for more tests. A doctor slid a long needle into his hip bone and drew out marrow for analysis.

"We looked at the slide together," Dr. Wartman said. "It was packed with leukemia cells. I was in a state of shock."

Dr. Wartman underwent nine months of intensive chemotherapy, followed by 15 months of maintenance chemotherapy. Five years passed when the cancer seemed to be gone. But then it came back. Next came intensive chemotherapy, to put the cancer into remission, followed by a bone-marrow transplant from his younger brother.

Seven months after the transplant, he went to a major cancer meeting and sat in on a session on his type of leukemia. The speaker reported that only 4 or 5 percent of those who relapsed survived.

"My stomach turned," Dr. Wartman said. "I will never forget the shock of hearing that number."

By last spring, three years after his transplant, Dr. Wartman was running nine to eleven kilometers every other day and feeling good. "I thought maybe I would run a half marathon in the fall."

Then the cancer came back.

A Clue in RNA

Dr. Wartman's doctors realized then that their last best hope for saving him was to use all the genetic know-how and technology at their disposal.

After their month of frantic work to beat cancer's relentless clock, the group had the data.

The cancer's DNA had many mutations, but there was nothing to be done about them. There were no drugs to attack them.

But the other analysis, of the cancer's RNA, showed that a normal gene, FLT3, was wildly active in the leukemia cells. Its normal role is to make cells grow and proliferate. An overactive FLT3 gene might be making Dr. Wartman's cancer cells multiply so quickly.

Even better, there was a drug, sunitinib or Sutent, approved for treating advanced kidney cancer, that inhibits FLT3.

But it costs $330 a day, and Dr. Wartman's insurance company would not pay for it. He also pleaded with the drug's maker, Pfizer, to give him the drug under its compassionate use program, explaining that his entire salary was only enough to pay for

7 1/2 months of Sutent. But Pfizer turned him down too.

He gathered up the money to buy a week's worth and began taking it. Within days, his blood counts were looking more normal.But he said he was afraid to hope, and the cost of the drug nagged at him. If it worked, how long could he afford to keep taking it?

The next day, a nurse at the hospital pharmacy called with what seemed miraculous news: a month's supply of Sutent was waiting for Dr. Wartman. The doctors in his division had pitched in to buy the drug.

Two weeks later, his bone marrow, which had been full of leukemia cells, was clean, a biopsy showed. Two more sensitive tests confirmed the cancer's remission. "I can't believe it," his physician, Dr. John DiPersio, told him.

Hunches and Decisions

Dr. Wartman's doctors considered whether he should keep taking Sutent or have another bone-marrow transplant now that he was in remission again.

In the end, Dr. DiPersio decided Dr. Wartman should have the transplant because without it the cancer might mutate and escape the Sutent. Meanwhile, Pfizer had decided to give him the drug.

Dr. Wartman's cancer is gone, for now, but he has struggled with a common complication of bone-marrow transplants, in which the white blood cells of the transplanted marrow attack his cells as though they were foreign. He has had rashes and felt ill. But these complications are lessening, and he is back at work in Dr. Ley's lab.

His colleagues want to look for the same mutation in the cancer cells of other patients with his cancer. And they would like to start a clinical trial testing Sutent to discover whether the drug can help others with leukemia, or whether the solution they found was unique to Lukas Wartman.

Dr. Wartman himself is left with nagging uncertainties. He knows how lucky he is, but what does the future hold? Can he plan a life? Is he cured?

"It's a hard feeling to describe," he said. "I am in uncharted waters."

The New York Times

(China Daily 07/29/2012 page11)

久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    成人av第一页| 美女爽到高潮91| 一本大道久久a久久精二百| 亚洲色图在线看| 欧洲人成人精品| 一区二区不卡在线播放| 欧美片网站yy| 麻豆免费精品视频| 欧美精品一区二区三区蜜桃视频| 国产尤物一区二区在线| 国产精品久久99| 欧美综合色免费| 蜜臀久久99精品久久久画质超高清 | 美女一区二区三区| 久久精品夜夜夜夜久久| 91网站在线观看视频| 午夜精品久久久久久久99樱桃| 欧美岛国在线观看| 成人国产精品免费观看视频| 亚洲综合色区另类av| 欧美一二三四在线| 成人综合婷婷国产精品久久免费| 亚洲精品国久久99热| 91麻豆精品91久久久久同性| 国产成人啪免费观看软件| 亚洲精品视频在线| 日韩午夜激情视频| caoporn国产一区二区| 99久久精品免费| 亚洲欧美一区二区不卡| 欧美一区二区免费观在线| 国产大片一区二区| 亚洲一区二区在线观看视频| 337p日本欧洲亚洲大胆精品 | 精品女同一区二区| 色域天天综合网| 久久99精品国产| 亚洲免费观看在线观看| 日韩欧美视频一区| 99久久夜色精品国产网站| 五月天婷婷综合| 国产精品欧美综合在线| 欧美一三区三区四区免费在线看 | 亚洲欧美日韩国产一区二区三区| 91精品国产高清一区二区三区| 成人午夜电影久久影院| 日本不卡在线视频| 国产精品国产a| 日韩三级在线观看| 色婷婷综合久久久中文一区二区 | 欧美不卡一区二区三区四区| 一本久久a久久免费精品不卡| 激情五月激情综合网| 亚洲久本草在线中文字幕| 欧美大白屁股肥臀xxxxxx| 91官网在线观看| 福利电影一区二区三区| 日韩在线一二三区| 亚洲免费观看高清完整版在线观看| 欧美大片一区二区| 欧美日韩国产电影| 93久久精品日日躁夜夜躁欧美| 久久国产剧场电影| 亚洲成人三级小说| 亚洲日本丝袜连裤袜办公室| 久久理论电影网| 7777精品伊人久久久大香线蕉超级流畅| 成人午夜在线免费| 久久99精品国产麻豆婷婷洗澡| 亚洲国产aⅴ成人精品无吗| 国产精品九色蝌蚪自拍| 久久在线免费观看| 7777精品伊人久久久大香线蕉 | www.色综合.com| 毛片基地黄久久久久久天堂| 亚洲曰韩产成在线| 亚洲婷婷综合色高清在线| 久久久久9999亚洲精品| 日韩美女一区二区三区| 欧美福利视频导航| 欧美性生交片4| 色综合天天做天天爱| 国产成都精品91一区二区三| 激情综合色播五月| 天天综合色天天综合色h| 一区二区在线观看av| 国产精品久久久久久久久果冻传媒 | 欧美日韩精品久久久| 色婷婷一区二区三区四区| 成人国产一区二区三区精品| 激情综合网av| 久久精品国产精品亚洲综合| 日韩高清在线观看| 丝袜国产日韩另类美女| 亚洲国产视频在线| 一个色妞综合视频在线观看| 中文字幕日韩一区| 国产精品欧美久久久久无广告| 久久精品一区四区| 久久久久久久国产精品影院| 精品国产乱码久久久久久久久| 日韩视频免费观看高清完整版在线观看 | 高清不卡一区二区在线| 国产福利一区二区三区视频在线| 韩国精品免费视频| 国产真实乱子伦精品视频| 精品亚洲porn| 狠狠色丁香婷综合久久| 国产真实乱偷精品视频免| 国产在线一区观看| 国产电影精品久久禁18| 粉嫩av一区二区三区粉嫩| 成人午夜看片网址| 99精品在线观看视频| 色婷婷国产精品| 在线视频欧美精品| 欧美日韩亚洲综合| 8v天堂国产在线一区二区| 91精品国产aⅴ一区二区| 精品日产卡一卡二卡麻豆| 久久只精品国产| 国产精品无人区| 综合久久给合久久狠狠狠97色| 亚洲精品一二三四区| 亚洲午夜免费视频| 人人狠狠综合久久亚洲| 国产资源精品在线观看| 成人国产精品免费观看动漫| 91丨九色丨黑人外教| 欧美无砖专区一中文字| 欧美一区二视频| 久久亚洲二区三区| 国产精品久久久久aaaa| 亚洲精品成人在线| 天堂一区二区在线| 国产一区二区在线视频| 不卡一卡二卡三乱码免费网站| 在线免费观看日韩欧美| 91精品国产欧美一区二区成人| 亚洲精品在线电影| 国产精品第五页| 亚洲国产另类av| 激情综合色播五月| 91原创在线视频| 337p亚洲精品色噜噜| 久久美女高清视频| 一区二区三区中文在线| 日日夜夜精品视频天天综合网| 国产一区在线看| 99精品视频在线观看| 69久久夜色精品国产69蝌蚪网| 久久伊99综合婷婷久久伊| 亚洲色图自拍偷拍美腿丝袜制服诱惑麻豆 | 中文字幕欧美激情一区| 一区二区在线电影| 久久se这里有精品| 一本色道**综合亚洲精品蜜桃冫| 91麻豆精品久久久久蜜臀 | 综合婷婷亚洲小说| 男人的j进女人的j一区| 成人午夜av影视| 欧美美女一区二区| 国产精品欧美久久久久一区二区| 亚洲图片欧美色图| 国产凹凸在线观看一区二区| 欧美日韩在线亚洲一区蜜芽| 国产校园另类小说区| 亚洲成人av福利| 成人自拍视频在线| 制服丝袜一区二区三区| 国产精品国产三级国产aⅴ中文 | 亚洲综合色网站| 国产一区二区精品在线观看| 欧美亚洲国产一区二区三区va| 久久伊人中文字幕| 亚洲成av人影院| 国产suv精品一区二区三区| 欧美日韩国产大片| 中文字幕在线不卡国产视频| 老汉av免费一区二区三区| 在线一区二区三区四区| 久久久久国产精品人| 日韩精品一二三| 99久久精品一区二区| 久久品道一品道久久精品| 午夜精品久久久久久久久久| 99久久精品国产导航| 久久综合九色综合97婷婷女人| 亚洲成人自拍网| 99riav一区二区三区| 久久久久久久久蜜桃| 日韩成人av影视| 色嗨嗨av一区二区三区| 久久精品视频在线看| 蜜臀av一区二区| 欧美性猛交一区二区三区精品 | 中国av一区二区三区| 久久66热偷产精品| 欧美日韩一级片网站| 亚洲欧洲www|